These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37400043)

  • 1. Prospect of targeting lysine methyltransferase NSD3 for tumor therapy.
    Li D; Tian T; Ko CN; Yang C
    Pharmacol Res; 2023 Aug; 194():106839. PubMed ID: 37400043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NSD3-Induced Methylation of H3K36 Activates NOTCH Signaling to Drive Breast Tumor Initiation and Metastatic Progression.
    Jeong GY; Park MK; Choi HJ; An HW; Park YU; Choi HJ; Park J; Kim HY; Son T; Lee H; Min KW; Oh YH; Lee JY; Kong G
    Cancer Res; 2021 Jan; 81(1):77-90. PubMed ID: 32967925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth.
    Sun Y; Xie J; Cai S; Wang Q; Feng Z; Li Y; Lu JJ; Chen W; Ye Z
    Cell Death Dis; 2021 Oct; 12(10):913. PubMed ID: 34615858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NSD3: Advances in cancer therapeutic potential and inhibitors research.
    Xiu S; Chi X; Jia Z; Shi C; Zhang X; Li Q; Gao T; Zhang L; Liu Z
    Eur J Med Chem; 2023 Aug; 256():115440. PubMed ID: 37182335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure, Activity and Function of the NSD3 Protein Lysine Methyltransferase.
    Rathert P
    Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel class inhibitors of NSD3 methyltransferase showing a unique, bivalent binding mode in the SET domain.
    Kim S; Hwang I; Kim SH; Chung HW; Ji MJ; Moon S; Park HM; Kong G; Hur W
    Chem Biol Drug Des; 2023 Sep; 102(3):500-513. PubMed ID: 37072259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [NSD3 suppresses LPS-triggered TNF-α production via promoting the dimethylation of histone H3K36 in macrophages].
    Liu Z; Cheng Q; Yang L; Sun Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jun; 34(6):481-487. PubMed ID: 30236198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a potent and selective proteolysis targeting chimera (PROTAC) degrader of NSD3 histone methyltransferase.
    Sun Y; Zhang Y; Chen X; Yu A; Du W; Huang Y; Wu F; Yu L; Li J; Wen C; Yang H; Shi Q; Geng M; Huang X; Xu S
    Eur J Med Chem; 2022 Sep; 239():114528. PubMed ID: 35717870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors.
    Topchu I; Pangeni RP; Bychkov I; Miller SA; Izumchenko E; Yu J; Golemis E; Karanicolas J; Boumber Y
    Cell Mol Life Sci; 2022 May; 79(6):285. PubMed ID: 35532818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions.
    Nuñez Y; Vera S; Baeza V; Gonzalez-Pecchi V
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC Interaction.
    Xiong J; Pecchi VG; Qui M; Ivanov AA; Mo X; Niu Q; Chen X; Fu H; Du Y
    Assay Drug Dev Technol; 2018; 16(2):96-106. PubMed ID: 29634317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of histone methyltransferase NSD3 reduces cell viability in osteosarcoma with induction of apoptosis.
    Liu Z; Piao L; Zhuang M; Qiu X; Xu X; Zhang D; Liu M; Ren D
    Oncol Rep; 2017 Nov; 38(5):2796-2802. PubMed ID: 28901481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of NSD3 (WHSC1L1) inhibits cell proliferation and migration via ERK1/2 deactivation and decreasing CAPG expression in colorectal cancer cells.
    Yi L; Yi L; Liu Q; Li C
    Onco Targets Ther; 2019; 12():3933-3943. PubMed ID: 31190890
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of histone lysine methyltransferase NSD3 in cancer.
    Han X; Piao L; Zhuang Q; Yuan X; Liu Z; He X
    Onco Targets Ther; 2018; 11():3847-3852. PubMed ID: 30013365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated NSD3 histone methylation activity drives squamous cell lung cancer.
    Yuan G; Flores NM; Hausmann S; Lofgren SM; Kharchenko V; Angulo-Ibanez M; Sengupta D; Lu X; Czaban I; Azhibek D; Vicent S; Fischle W; Jaremko M; Fang B; Wistuba II; Chua KF; Roth JA; Minna JD; Shao NY; Jaremko Ł; Mazur PK; Gozani O
    Nature; 2021 Feb; 590(7846):504-508. PubMed ID: 33536620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of nucleosomal H3K36 methylation by NSD methyltransferases.
    Li W; Tian W; Yuan G; Deng P; Sengupta D; Cheng Z; Cao Y; Ren J; Qin Y; Zhou Y; Jia Y; Gozani O; Patel DJ; Wang Z
    Nature; 2021 Feb; 590(7846):498-503. PubMed ID: 33361816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The methyltransferase NSD3 promotes antiviral innate immunity via direct lysine methylation of IRF3.
    Wang C; Wang Q; Xu X; Xie B; Zhao Y; Li N; Cao X
    J Exp Med; 2017 Dec; 214(12):3597-3610. PubMed ID: 29101251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into the C-terminus of the histone-lysine N-methyltransferase NSD3 by small-angle X-ray scattering.
    Belviso BD; Shen Y; Carrozzini B; Morishita M; di Luccio E; Caliandro R
    Front Mol Biosci; 2024; 11():1191246. PubMed ID: 38516186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NSD3, a member of nuclear receptor-binding SET domain family, is a potential prognostic biomarker for pancreatic cancer.
    Xiong Q; Zhou Y; Zhang S; Zhang Y; Xu Y; Yang Y; Zhou C; Zeng Z; Han J; Zhu Q
    Cancer Med; 2023 May; 12(9):10961-10978. PubMed ID: 37062069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.
    Rahman S; Sowa ME; Ottinger M; Smith JA; Shi Y; Harper JW; Howley PM
    Mol Cell Biol; 2011 Jul; 31(13):2641-52. PubMed ID: 21555454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.